Anixa Biosciences, Inc. (ANIX) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)

A side-by-side comparison of Anixa Biosciences, Inc. and Corbus Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIX vs CRBP

growth of $100 · dividends reinvested · last 10y
ANIX -39.3% (-4.9%/yr)CRBP -98.0% (-32.2%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$61$2
ANIX CRBP

ANIX vs CRBP: by the numbers

  • •CRBP is the larger company ($108M vs $103M market cap).

Metrics side by side

Valuation

MetricANIXCRBP
P/B ratio7.121.05

Profitability

MetricANIXCRBP
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-72.02%-99.67%
ROIC-82.35%-101.30%

Growth (annualized)

MetricANIXCRBP
Total return CAGR (5Y)-8.26%-28.32%

Frequently asked

How have ANIX and CRBP total returns compared?
Over the past 10 years, ANIX delivered -4.65% and CRBP delivered -31.74% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.